IASLC Launches Beta Version of VIKTOR

… In today’s digital landscape, clinicians and researchers in thoracic oncology can access a wealth of … of data—knowledge that is essential to advancing cancer research, developing new therapies, and ultimately saving … Virtual International Knowledgebase for Thoracic Oncology Research (VIKTOR)—a bioinformatics platform offering a unified …

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

… the US Veterans Health Administration (VA). 5 , 7  This research sought to determine the key components … the trials were conducted in 76 clinics with over 5,700 research participants nationwide.   SCALE Collaboration … support was delivered to clinical providers; of note, the research team did not intervene directly with patients. 20 …

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

… Dr. Hirsch’s significant contributions to international research and education. … Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award …

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

IASLC, LCRF Request Proposals for New Research Grant

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

In Case You Missed It: IASLC Launches New Education Center

Tobacco Control Committee Chair Discusses Recent Legislative, Research Developments

… Control Committee Chair Discusses Recent Legislative, Research Developments … Erin Jungmeyer …

Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date

… Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date …

Journal of Thoracic Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor

… Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor … Erin Jungmeyer …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …